Kavita Patel, a director at $ACLX ($ACLX), sold 1,400 shares of the company on 12-24-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 93.3% of their shares. Following this trade, they now own 100 shares of $ACLX stock.
$ACLX Insider Trading Activity
$ACLX insiders have traded $ACLX stock on the open market 46 times in the past 6 months. Of those trades, 0 have been purchases and 46 have been sales.
Here’s a breakdown of recent trading of $ACLX stock by insiders over the last 6 months:
- KAVITA PATEL has traded it 21 times. They made 0 purchases and 21 sales, selling 69,479 shares.
- MICHELLE GILSON (CHIEF FINANCIAL OFFICER) has traded it 9 times. They made 0 purchases and 9 sales, selling 29,115 shares.
- CHRISTOPHER HEERY (CHIEF MEDICAL OFFICER) has traded it 16 times. They made 0 purchases and 16 sales, selling 114,358 shares.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ACLX Hedge Fund Activity
We have seen 105 institutional investors add shares of $ACLX stock to their portfolio, and 100 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SUVRETTA CAPITAL MANAGEMENT, LLC removed 826,304 shares (-54.5%) from their portfolio in Q3 2024
- BLACKROCK, INC. added 730,328 shares (+20.8%) to their portfolio in Q3 2024
- GREAT POINT PARTNERS LLC removed 392,000 shares (-79.7%) from their portfolio in Q3 2024
- CORMORANT ASSET MANAGEMENT, LP removed 275,000 shares (-18.0%) from their portfolio in Q3 2024
- PRICE T ROWE ASSOCIATES INC /MD/ added 269,921 shares (+16.6%) to their portfolio in Q3 2024
- PFM HEALTH SCIENCES, LP removed 251,378 shares (-80.6%) from their portfolio in Q3 2024
- RA CAPITAL MANAGEMENT, L.P. added 247,465 shares (+15.4%) to their portfolio in Q3 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
